AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
ORAL DOXIFLURIDINE (5-DFUR) AND RADIATION-THERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC-CANCER - A PHASE-II STUDY OF ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP
Authors: BAJETTA E DIBARTOLOMEO M ARTALE S STANI S RICCI SB CASSATA A MAZZAFERRO V BOZZETTI F
Citation: E. Bajetta et al., ORAL DOXIFLURIDINE (5-DFUR) AND RADIATION-THERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC-CANCER - A PHASE-II STUDY OF ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP, Annals of oncology, 9, 1998, pp. 240-240
ORAL DOXIFLURIDINE PLUS LEVOLEUCOVORIN IN ELDERLY PATIENTS WITH ADVANCED BREAST-CANCER
Authors: BAJETTA E BIGANZOLI L CARNAGHI C DIBARTOLOMEO M SPAGNOLI I CASSATA A GALANTE E MARIANI L STAMPINO CG BUZZONI R
Citation: E. Bajetta et al., ORAL DOXIFLURIDINE PLUS LEVOLEUCOVORIN IN ELDERLY PATIENTS WITH ADVANCED BREAST-CANCER, Cancer, 83(6), 1998, pp. 1136-1141
5-FLUOROURACIL, DACARBAZINE, AND EPIRUBICIN IN THE TREATMENT OF PATIENTS WITH NEUROENDOCRINE TUMORS
Authors: BAJETTA E RIMASSA L CARNAGHI C SEREGNI E FERRARI L DIBARTOLOMEO M REGALIA E CASSATA A PROCOPIO G MARIANI L
Citation: E. Bajetta et al., 5-FLUOROURACIL, DACARBAZINE, AND EPIRUBICIN IN THE TREATMENT OF PATIENTS WITH NEUROENDOCRINE TUMORS, Cancer, 83(2), 1998, pp. 372-378
FEP REGIMEN (EPIDOXORUBICIN, ETOPOSIDE AND CISPLATIN) IN ADVANCED GASTRIC-CANCER, WITH OR WITHOUT LOW-DOSE GM-CSF - AN ITALIAN TRIAL IN MEDICAL ONCOLOGY (ITMO) STUDY
Authors: BAJETTA E DIBARTOLOMEO M CARNAGHI C BUZZONI R MARIANI L GEBBIA V COMELLA G PINOTTI G IANNIELLO G SCHIEPPATI G BOCHICCHIO AM MAIORINO L
Citation: E. Bajetta et al., FEP REGIMEN (EPIDOXORUBICIN, ETOPOSIDE AND CISPLATIN) IN ADVANCED GASTRIC-CANCER, WITH OR WITHOUT LOW-DOSE GM-CSF - AN ITALIAN TRIAL IN MEDICAL ONCOLOGY (ITMO) STUDY, British Journal of Cancer, 77(7), 1998, pp. 1149-1154
DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS
Authors: BAJETTA E DIBARTOLOMEO M SOMMA L DELVECCHIO M ARTALE S ZUNINO F BIGNAMI P MAGNANI E BUZZONI R
Citation: E. Bajetta et al., DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS, European journal of cancer, 33(4), 1997, pp. 687-690
GLUTAMINE SUPPLEMENTATION IN CANCER-PATIENTS RECEIVING CHEMOTHERAPY -A DOUBLE-BLIND RANDOMIZED STUDY
Authors: BOZZETTI F BIGANZOLI L GAVAZZI C CAPPUZZO F CARNAGHI C BUZZONI R DIBARTOLOMEO M BAIETTA E
Citation: F. Bozzetti et al., GLUTAMINE SUPPLEMENTATION IN CANCER-PATIENTS RECEIVING CHEMOTHERAPY -A DOUBLE-BLIND RANDOMIZED STUDY, Nutrition, 13(7-8), 1997, pp. 748-751
PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH PRETREATED ADVANCED OVARIAN-CANCER - ACTIVITY IN PLATINUM-RESISTANT DISEASE
Authors: BAJETTA E DILEO A BIGANZOLI L MARIANI L CAPPUZZO F DIBARTOLOMEO M ZILEMBO N ARTALE S MAGNANI E CELIO L BUZZONI R CARNAGHI C
Citation: E. Bajetta et al., PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH PRETREATED ADVANCED OVARIAN-CANCER - ACTIVITY IN PLATINUM-RESISTANT DISEASE, Journal of clinical oncology, 14(9), 1996, pp. 2546-2551
DOXIFLURIDINE AS PALLIATIVE TREATMENT IN ADVANCED GASTRIC AND PANCREATIC-CANCER PATIENTS
Authors: DIBARTOLOMEO M BAJETTA E SOMMA L CARNAGHI C BANDIERI E DELVECCHIO M STAMPINO CG BUZZONI R
Citation: M. Dibartolomeo et al., DOXIFLURIDINE AS PALLIATIVE TREATMENT IN ADVANCED GASTRIC AND PANCREATIC-CANCER PATIENTS, Oncology, 53(1), 1996, pp. 54-57
RANDOMIZED PHASE-II NONCOMPARATIVE TRIAL OF ORAL AND INTRAVENOUS DOXIFLURIDINE PLUS LEVO-LEUCOVORIN IN UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
Authors: BAJETTA E DIBARTOLOMEO M SOMMA L MORESCHI M COMELLA G TURCI D GEBBIA V SCANNI A BORDOGNA G STAMPINO CG
Citation: E. Bajetta et al., RANDOMIZED PHASE-II NONCOMPARATIVE TRIAL OF ORAL AND INTRAVENOUS DOXIFLURIDINE PLUS LEVO-LEUCOVORIN IN UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Cancer, 78(10), 1996, pp. 2087-2093
CLINICAL EFFICACY OF OCTREOTIDE IN THE TREATMENT OF METASTATIC NEUROENDOCRINE TUMORS - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP
Authors: DIBARTOLOMEO M BAJETTA E BUZZONI R MARIANI L CARNAGHI C SOMMA L ZILEMBO N DILEO A
Citation: M. Dibartolomeo et al., CLINICAL EFFICACY OF OCTREOTIDE IN THE TREATMENT OF METASTATIC NEUROENDOCRINE TUMORS - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP, Cancer, 77(2), 1996, pp. 402-408
PHASE-II TRIAL OF ORAL DOXIFLURIDINE PLUS ORAL LEVO-LEUCOVORIN IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA
Authors: COLLEONI M DIBARTOLOMEO M BAJETTA E NOLE F NELLI P CARNAGHI C VICARIO G DELVECCHIO M BONO A
Citation: M. Colleoni et al., PHASE-II TRIAL OF ORAL DOXIFLURIDINE PLUS ORAL LEVO-LEUCOVORIN IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA, Oncology Reports, 2(4), 1995, pp. 603-606
DOXIFLURIDINE IN PATIENTS WITH 5-FU RESISTANT COLORECTAL-CANCER
Authors: BAJETTA E DIBARTOLOMEO M SOMMA L VICARIO G CELIO L BIGNAMI P BANDIERI E BALDINI M
Citation: E. Bajetta et al., DOXIFLURIDINE IN PATIENTS WITH 5-FU RESISTANT COLORECTAL-CANCER, European journal of cancer, 31A, 1995, pp. 705-705
DOXIFLURIDINE IN ADVANCED COLORECTAL-CARCINOMA - PARALLEL MULTICENTERRANDOMIZED PHASE-II TRIAL
Authors: DIBARTOLOMEO M SOMMA L BAJETTA E BUZZONI R MORESCHI M CASARETTI R TURCI D GEBBIA V DIMAIUTA MS BORDOGNA G COLLEONI M MANTOVANI G RABBI C BARNI S FERRARI VD MARINI G STAMPINO CG
Citation: M. Dibartolomeo et al., DOXIFLURIDINE IN ADVANCED COLORECTAL-CARCINOMA - PARALLEL MULTICENTERRANDOMIZED PHASE-II TRIAL, European journal of cancer, 31A, 1995, pp. 719-719
ORAL CHEMOTHERAPY WITH DOXIFLURIDINE AND FOLINIC ACID IN BILIARY-TRACT CANCER
Authors: COLLEONI M DIBARTOLOMEO M DILEO A ZILEMBO N CARNAGHI C PANDOLFI A RIMASSA L ARTALE S BAJETTA E
Citation: M. Colleoni et al., ORAL CHEMOTHERAPY WITH DOXIFLURIDINE AND FOLINIC ACID IN BILIARY-TRACT CANCER, European journal of cancer, 31A(13-14), 1995, pp. 2426-2427
A PHASE-II TRIAL OF DACARBAZINE, FLUOROURACIL AND EPIRUBICIN IN PATIENTS WITH NEUROENDOCRINE TUMORS - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP
Authors: DIBARTOLOMEO M BAJETTA E BOCHICCHIO AM CARNAGHI C SOMMA L MAZZAFERRO V VISINI M GEBBIA V TUMOLO S BALLATORE P
Citation: M. Dibartolomeo et al., A PHASE-II TRIAL OF DACARBAZINE, FLUOROURACIL AND EPIRUBICIN IN PATIENTS WITH NEUROENDOCRINE TUMORS - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP, Annals of oncology, 6(1), 1995, pp. 77-79
DOXIFLURIDINE AND LEUCOVORIN - AN ORAL TREATMENT COMBINATION IN ADVANCED COLORECTAL-CANCER
Authors: BAJETTA E COLLEONI M DIBARTOLOMEO M BUZZONI R BOZZETTI F DOCI R SOMMA L CAPPUZZO F STAMPINO CG GUENZI A BALANT LP ZILEMBO N DILEO A
Citation: E. Bajetta et al., DOXIFLURIDINE AND LEUCOVORIN - AN ORAL TREATMENT COMBINATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2613-2619
DOXIFLURIDINE - AN ACTIVE AGENT IN ADVANCED GASTROINTESTINAL CANCER
Authors: DIBARTOLOMEO M BAJETTA E SOMMA L BUZZONI R
Citation: M. Dibartolomeo et al., DOXIFLURIDINE - AN ACTIVE AGENT IN ADVANCED GASTROINTESTINAL CANCER, Tumori, 81(3), 1995, pp. 147-150
FEASIBILITY OF INTRAPORTAL CHEMOTHERAPY WITH FLUOROURACIL AND FOLINICACID IMMEDIATELY AFTER HEPATIC RESECTION FOR COLORECTAL METASTASES
Authors: BIGNAMI P DOCI R MONTALTO F FISSI S DIBARTOLOMEO M GENNARI L
Citation: P. Bignami et al., FEASIBILITY OF INTRAPORTAL CHEMOTHERAPY WITH FLUOROURACIL AND FOLINICACID IMMEDIATELY AFTER HEPATIC RESECTION FOR COLORECTAL METASTASES, Tumori, 81(2), 1995, pp. 96-101
PHASE-II STUDY OF THE ETOPOSIDE, LEUCOVORIN AND FLUOROURACIL COMBINATION FOR PATIENTS WITH ADVANCED GASTRIC-CANCER UNSUITABLE FOR AGGRESSIVE CHEMOTHERAPY
Authors: DIBARTOLOMEO M BAJETTA E DEBRAUD F BOCHICCHIO AM GEBBIA V BOZZETTI F DOCI R BONFANTI G COZZAGLIO L
Citation: M. Dibartolomeo et al., PHASE-II STUDY OF THE ETOPOSIDE, LEUCOVORIN AND FLUOROURACIL COMBINATION FOR PATIENTS WITH ADVANCED GASTRIC-CANCER UNSUITABLE FOR AGGRESSIVE CHEMOTHERAPY, Oncology, 52(1), 1995, pp. 41-44
ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF EXEMESTANE, A NEW STEROIDALAROMATASE INHIBITOR
Authors: ZILEMBO N NOBERASCO C BAJETTA E MARTINETTI A MARIANI L OREFICE S BUZZONI R DIBARTOLOMEO M DILEO A LAFFRANCHI A DISALLE E
Citation: N. Zilembo et al., ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF EXEMESTANE, A NEW STEROIDALAROMATASE INHIBITOR, British Journal of Cancer, 72(4), 1995, pp. 1007-1012
ETOPOSIDE, DOXORUBICIN AND CISPLATIN (EAP) TREATMENT IN ADVANCED GASTRIC-CARCINOMA - A MULTICENTER STUDY OF THE ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP
Authors: BAJETTA E DIBARTOLOMEO M DEBRAUD F BOZZETTI F BOCHICCHIO AM COMELLA P FAGNANI D FARINA G FERRONI C FRANCHI R GEBBIA V IANNIELLO G IIRILLO A PINOTTI G SCHIEPPATI G UCCI G VISINI M ZANIBONI A BUZZONI R CASARTELLI C NELLI P
Citation: E. Bajetta et al., ETOPOSIDE, DOXORUBICIN AND CISPLATIN (EAP) TREATMENT IN ADVANCED GASTRIC-CARCINOMA - A MULTICENTER STUDY OF THE ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP, European journal of cancer, 30A(5), 1994, pp. 596-600
CONTROL OF EMESIS BY A LOW-DOSE OF ONDANSETRON AND DEXAMETHASONE
Authors: DIBARTOLOMEO M BAJETTA E BIGANZOLI L DILEO A BUZZONI R ZAMPINO MG
Citation: M. Dibartolomeo et al., CONTROL OF EMESIS BY A LOW-DOSE OF ONDANSETRON AND DEXAMETHASONE, Tumori, 80(2), 1994, pp. 131-134
EPIRUBICIN, ETOPOSIDE AND CISPLATIN IN ADVANCED PANCREATIC-CARCINOMA
Authors: DIBARTOLOMEO M ZAMPINO MG DILEO A BAJETTA E
Citation: M. Dibartolomeo et al., EPIRUBICIN, ETOPOSIDE AND CISPLATIN IN ADVANCED PANCREATIC-CARCINOMA, European journal of cancer, 29A(8), 1993, pp. 1215-1216
MEDICAL-TREATMENT OF NEUROENDOCRINE TUMORS
Authors: BAJETTA E DIBARTOLOMEO M ZILEMBO N BOCHICCHIO AM
Citation: E. Bajetta et al., MEDICAL-TREATMENT OF NEUROENDOCRINE TUMORS, Tumori, 79(6), 1993, pp. 380-388
TREATMENT OF CARCINOID-SYNDROME WITH RECOMBINANT INTERFERON-ALPHA-2A
Authors: DIBARTOLOMEO M BAJETTA E ZILEMBO N DEBRAUD F DILEO A VERUSIO C DAPRILE M SCANNI A IIRILLO A BARDUAGNI A EPIFANI C
Citation: M. Dibartolomeo et al., TREATMENT OF CARCINOID-SYNDROME WITH RECOMBINANT INTERFERON-ALPHA-2A, Acta oncologica, 32(2), 1993, pp. 235-238
Risultati: 1-25 | 26-27